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Exercise exerts beneficial effects on systemic metabolism. A recent Nature paper (Bostro¨m et al., 2012)
identifies irisin as an exercise-induced hormone secreted by skeletal muscle in mice and humans. Irisin
promotes brown adipocyte recruitment in white fat and improves systemic metabolism by increasing energy
expenditure.Exercise promotes healthy systemic
metabolism and protects against meta-
bolic diseases such as diabetes. The
transcriptional coactivator PGC-1a stim-
ulates oxidative metabolism in skeletal
muscle and is considered to mediate
many of the downstream molecular
events induced by exercise. Previously,
Spiegelman and collaborators made the
observation that protection against age-
induced obesity and diabetes resulting
from transgenic overexpression ofmuscle
PGC-1a could not be solely attributed to
the local action of PGC-1a (Wenz et al.,
2009), which led them to hypothesize the
existence of a protein secreted by the
muscle that could mediate systemic
metabolic improvement. Using a combi-
nation of gene expression arrays and
computer-based prediction of protein
secretion approaches, Bostro¨m et al.
identified irisin, a signaling protein
released to blood by skeletal muscle after
proteolysis of the membrane protein
FNDC5 (Bostro¨m et al., 2012).
In this study, Bostro¨m et al. first
selected five PGC-1a target genes in
muscle encoding candidate proteins
likely to be secreted. Among them, only
FNDC5, the irisin precursor, induced the
differentiation of stromal vascular cells
isolated from mouse subcutaneous white
fat into a brown adipocyte phenotype.
The authors showed that exercise raised
circulating irisin levels and found that,
indeed, the main action of irisin was the
induction of brown adipocytes in white
adipose tissue depots, a process known
as white fat ‘‘browning’’ (Figure 1).
Rodents have depots of brown adipose
tissue (BAT) at distinct anatomical loca-
tions, which mainly develop during the
fetal period. After thermogenic activation,norepinephrine released by sympathetic
nervous endings activates BAT thermo-
genic activity. Activated BAT constitutes
a real sink for circulating lipids and glu-
cose that are intensely cleared and
oxidized to generate heat (Cannon and
Nedergaard, 2004). Thermogenesis in-
duction also involves the aforementioned
browning of white fat, and there is
evidence that exercise may indeed acti-
vate this process, though the physiolog-
ical benefit of exercise-induced thermo-
genesis remains to be determined.
Inducible brown adipocytes, named brite
or beige, do not arise from the same
lineage as myogenic cells and develop-
mentally programmed brown adipocytes
(Seale et al., 2008), and the cellular mech-
anisms underlying the browning process
remain controversial. Most authors think
that, upon a given stimulus, precursor
cells in white adipose depots differentiate
to acquire a brown instead of a white
adipocyte phenotype, while other groups
claim that trans-differentiation of mature
white adipocytes into brown adipocytes
may occur (Barbatelli et al., 2010). In this
study, Bostro¨m et al. showed that the
former hypothesis was prevalent for irisin
effects, as it promoted brown adipocyte
differentiation of precursor cells in culture.
Bostro¨m et al. next further investigated
the powerful impact of irisin on whole-
body metabolic homeostasis. They ob-
served that in obese mice, an experi-
mental increase in irisin levels achieved
through adenoviral-mediated overex-
pression of FNDC5 in mouse liver, the
precursor of irisin, caused white fat
browning, weight loss, enhanced oxygen
consumption, improved glucose toler-
ance, and insulin sensitization. Con-
versely, neutralization of circulating irisinCell Metabolismusing a blocking antibody impaired exer-
cise-mediated induction of browning. A
precise assessment of the relative contri-
bution of white fat browning relative to the
stimulation of already-differentiated BAT
depots on overall energy expenditure
and glucose homeostasis is lacking at
present, and definitive cause-to-effect
relationship remains to be established.
Several questions arise over the
discovery of a new endocrine system
such as the irisin-browning axis. Since
our initial analysis of GEO (Gene Expres-
sion Omnibus) and UniGene databases
for FNDC5 expression identifies heart
and liver as additional potential sites of
expression, it would be interesting to
testwhether irisin acts as a cardiomyokine
or a hepatokine as well. Moreover, it will
be important to characterize irisin recep-
tors and associated downstream signal-
ing pathways. A first interesting observa-
tion is the involvement of PPARa,
evidenced by the fact that GW6471, a
pharmacological inhibitor of PPARa,
blunts the capacity of precursor cells to
acquire a brown adipocyte phenotype in
response to irisin. PPARa is a nuclear
receptor that acts as a master transcrip-
tional regulator of lipid catabolism and
coordinates fat oxidation with thermogen-
esis (Barbera et al., 2001). Although
PPARa has not been directly involved in
brown adipogenic differentiation, recent
data indicate a complex crosstalk with
PGC-1a and PRDM16 (Hondares et al.,
2011), which are pivotal actors in the tran-
scriptional control of brown adipocyte
differentiation.
Bostro¨m et al. also started addressing
the physiological relevance of the report-
ed findings in humans and described irisin
expression in human muscle as well as15, March 7, 2012 ª2012 Elsevier Inc. 277
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Figure 1. ‘‘Browning’’ Effect of Irisin in White Adipose Tissue
Irisin is released from skeletal muscle, especially after exercise. Irisin triggers the differentiation of
precursor cells present within the white adipose tissue into cells with brown adipocyte characteristics
such as high abundance of uncoupling protein-1, multilocular fat droplets, and mitochondria.
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its induction with exercise. However, the
existence of white fat browning in humans
has yet to be demonstrated. The anatom-
ical sites of BAT in adult humans concur
with recognizable BAT depots in fetuses
and neonates (Heaton, 1972), which
would suggest a composition of develop-
mentally programmed brown adipocytes.
It is tempting to speculate that humans
have the capacity to recruit novel brown
adipocytes in white fat depots after a
given stimulus, since the appearance of
brown adipocytes in formerly white fat
depots has been reported as a conse-
quence of the release of catecholamines278 Cell Metabolism 15, March 7, 2012 ª201by the pheochromocytoma tumor (Ricqu-
ier et al., 1982).
An important conclusion from the study
by Spiegelman and collaborators is that
brown adipocyte thermogenesis may be
promoted by signals from tissues and
organs other than the classical sympa-
thetic activation. Irisin can now be added
to the list of secreted proteins stimulating
brown adipocyte thermogenesis, along
with liver fibroblast growth factor-21
(Hondares et al., 2010) and cardiac natri-
uretic peptides (Bordicchia et al., 2012).
This growing recognition of nonadrener-
gic signals to induce brown adipocyte
activity and recruitment may be of utmost2 Elsevier Inc.interest to the development of pharmaco-
logical strategies to promote healthy
metabolic consequences of BAT activa-
tion. Moreover, pharmacological induc-
tion of irisin may be of interest to promote
weight loss and improve insulin sensitivity
in patients who cannot benefit from the
beneficial effects of exercise.
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